销售 更改
3i Infrastructure GBP 315M 91M 2025-09
AstraZeneca USD 15.5B 313M 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
Hikma Pharmaceutical USD 1.69B 863M 2025-12